Table 1.
Factor | Total | No COVID | COVID-19 infection | p-value |
---|---|---|---|---|
N = 4500 | n = 4075 | n = 425 | ||
Age (years) | 30.9 ± 5.7 | 31.1 ± 5.7 | 28.9 ± 6.1 | <0.001 |
Age | <0.001 | |||
1: ⩽25 | 859 (19.1%) | 722 (17.7%) | 137 (32.2%) | |
2: 26–34 | 2632 (58.5%) | 2414 (59.2%) | 218 (51.3%) | |
3: 35+ | 1009 (22.4%) | 939 (23.0%) | 70 (16.5%) | |
Race/ethnicity | <0.001 | |||
NH White | 1539 (34.2%) | 1462 (35.9%) | 77 (18.1%) | |
Hispanic | 1525 (33.9%) | 1286 (31.6%) | 239 (56.2%) | |
NH Black | 325 (7.2%) | 290 (7.1%) | 35 (8.2%) | |
NH Asian | 705 (15.7%) | 677 (16.6%) | 28 (6.6%) | |
Other | 406 (9.0%) | 360 (8.8%) | 46 (10.8%) | |
Insurance | <0.001 | |||
Commercial | 2239 (49.8%) | 2137 (52.4%) | 102 (24.0%) | |
Public | 1970 (43.8%) | 1666 (40.9%) | 304 (71.5%) | |
Other/self/unknown | 291 (6.5%) | 272 (6.7%) | 19 (4.5%) | |
Month | <0.001 | |||
October | 1586 (35.2%) | 1481 (36.3%) | 105 (24.7%) | |
November | 1492 (33.2%) | 1345 (33.0%) | 147 (34.6%) | |
December | 1422 (31.6%) | 1249 (30.7%) | 173 (40.7%) | |
Hypertension | 0.17 | |||
No | 4464 (99.2%) | 4040 (99.1%) | 424 (99.8%) | |
Yes | 36 (0.8%) | 35 (0.9%) | 1 (0.2%) | |
GDM | 0.40 | |||
No | 4056 (90.1%) | 3668 (90.0%) | 388 (91.3%) | |
Yes | 444 (9.9%) | 407 (10.0%) | 37 (8.7%) | |
Preeclampsia | 0.80 | |||
No | 4299 (95.5%) | 3894 (95.6%) | 405 (95.3%) | |
Yes | 201 (4.5%) | 181 (4.4%) | 20 (4.7%) | |
Birth type | 0.24 | |||
Vaginal | 3388 (75.3%) | 3058 (75.0%) | 330 (77.6%) | |
C-section | 1112 (24.7%) | 1017 (25.0%) | 95 (22.4%) | |
Parity | <0.001 | |||
Nulliparous | 1735 (38.6%) | 1616 (39.7%) | 119 (28.0%) | |
1+ previous | 2765 (61.4%) | 2459 (60.3%) | 306 (72.0%) | |
Blood type | 0.048 | |||
O | 2204 (49.0%) | 1984 (48.7%) | 220 (51.8%) | |
A | 1443 (32.1%) | 1297 (31.8%) | 146 (34.4%) | |
AB | 198 (4.4%) | 185 (4.5%) | 13 (3.1%) | |
B | 655 (14.6%) | 609 (14.9%) | 46 (10.8%) |
NH: non-Hispanic; GDM: gestational diabetes mellitus.